“…BSs' role as anti-adhesive agents against several pathogens, suitable anti-adhesive coating agents are suitable for medical insertional materials that can reduce a large number of hospital infections without (Hassan & Mohammad, 2015) Acinetobacter indicus NS NS Treatment of biofilms for seven days at 500 μg/ml resulted in up to 82.5% biofilm disruption (Karlapudi et al, 2018) B. subtilis Lipopeptide surfactin, iturin and fengycin Biofilm formation on uropathogenic bacteria reduced (Moryl, Spętana et al, 2015) Corynebacterium xerosis Lipopeptide Coryxin Disrupted preformed biofilms of E. coli (66%), S. mutans (80%), S. aureus (82.5%), and P. aeruginosa (30%). (Dalili, Amini et al, 2015) Fasciospongia cavernosa Lipopeptide NS 125 mg/ml of lipopeptide was effective in reducing the biofilm formation activity of pathogenic MDR S. aureus (Kiran, Priyadharsini et al, 2017) Bacillus licheniformis NS NS Inhibited P. aeruginosa and Vibrio harveyi biofilms on polystyrene surfaces up to around 78% and 80% respectively (Hamza, Kumar, & Zinjarde, 2016) S. lentus Glycolipid NS At a concentration of 20 μg was able to disrupt mature biofilms of V. harveyi (78.7 ± 1.93%) and P. aeruginosa (81.7 ± 0.59%; (Hamza, Satpute, Banpurkar, Kumar, & Zinjarde, 2017) Lactobacillus casei Glycolipid NS Potentially disrupted biofilm formation under dynamic conditions (Kiran, Sabarathnam, & Selvin, 2010) Lactobacillus jensenii and Lactobacillus gasseri NS NS Disrupted biofilms of E. coli, Enterobacter aerogenes and Staphylococcus saprophyticus (Morais, Cordeiro et al, 2017) Note. NS: not specified.…”